Literature DB >> 20352467

Does telomerase reverse transcriptase induce functional de-differentiation of human endothelial cells?

Yvonne Baumer1, Dorothee Funk, Burkhard Schlosshauer.   

Abstract

By counteracting the shortening of chromosome telomeres, telomerase reverse transcriptase (hTERT) prevents senescence and age-related cell death. Embryonic cells display a high telomerase activity that declines rapidly with cell differentiation. Conversely, de-differentiated tumor cells tend to re-express telomerase. In view of the controversial data on the reciprocal correlation between cell proliferation and differentiation, we questioned whether telomerase overexpression and the resulting immortalization would affect the functional phenotype of human endothelial cells. Our comparative analysis addressed (1) distinct cell adhesion to different ECM-proteins analyzed on miniaturized multisubstrate arrays (MSA), (2) protein expression of diverse markers, (3) the uptake of DiI-Ac-LDL, (4) the inflammatory response based on upregulation of ICAM-1, (5) tube formation, and (6) the barrier properties of cell monolayers in transfilter cultures. Our results, based on some 40 data sets, demonstrate that immortalization of primary endothelial cells by hTERT maintains the typical endothelial characteristics without any sign of functional de-differentiation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20352467     DOI: 10.1007/s00018-010-0349-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  63 in total

1.  In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R.

Authors:  Ronald E Unger; Vera Krump-Konvalinkova; Kirsten Peters; C James Kirkpatrick
Journal:  Microvasc Res       Date:  2002-11       Impact factor: 3.514

2.  VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide.

Authors:  Jerome W Breslin; Peter J Pappas; Joaquim J Cerveira; Robert W Hobson; Walter N Durán
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-09-12       Impact factor: 4.733

3.  Stopping the use of false "endothelial" cell lines.

Authors:  Armando Rojas; Ileana Gonzalez; Hector Figueroa
Journal:  Int Immunopharmacol       Date:  2008-11-17       Impact factor: 4.932

4.  An in vitro model for endothelial permeability: assessment of monolayer integrity.

Authors:  P W Kazakoff; T R McGuire; E B Hoie; M Cano; P L Iversen
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-12       Impact factor: 2.416

5.  LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis.

Authors:  C Mouta Carreira; S M Nasser; E di Tomaso; T P Padera; Y Boucher; S I Tomarev; R K Jain
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

6.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

7.  Human endothelial cell life extension by telomerase expression.

Authors:  J Yang; E Chang; A M Cherry; C D Bangs; Y Oei; A Bodnar; A Bronstein; C P Chiu; G S Herron
Journal:  J Biol Chem       Date:  1999-09-10       Impact factor: 5.157

8.  Genes involved in differentiation, stem cell renewal, and tumorigenesis are modulated in telomerase-immortalized human urothelial cells.

Authors:  Emma J Chapman; Gavin Kelly; Margaret A Knowles
Journal:  Mol Cancer Res       Date:  2008-07       Impact factor: 5.852

Review 9.  Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies.

Authors:  Gaia Spinetti; Nicolle Kraenkel; Costanza Emanueli; Paolo Madeddu
Journal:  Cardiovasc Res       Date:  2008-02-15       Impact factor: 10.787

10.  Immunoelectron characterisation of the inter-endothelial junctions of human term placenta.

Authors:  L Leach; P Clark; M G Lampugnani; A G Arroyo; E Dejana; J A Firth
Journal:  J Cell Sci       Date:  1993-04       Impact factor: 5.285

View more
  5 in total

Review 1.  Telomeres and tissue engineering: the potential roles of TERT in VEGF-mediated angiogenesis.

Authors:  Fernando P Hartwig; Fernanda Nedel; Tiago V Collares; Sandra B C Tarquinio; Jacques E Nör; Flávio F Demarco
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

2.  Telomerase activation in the treatment of aging or degenerative diseases: a systematic review.

Authors:  P Prieto-Oliveira
Journal:  Mol Cell Biochem       Date:  2020-10-01       Impact factor: 3.396

3.  Larrea tridentata: A novel source for anti-parasitic agents active against Entamoeba histolytica, Giardia lamblia and Naegleria fowleri.

Authors:  Bharat Bashyal; Linfeng Li; Trpta Bains; Anjan Debnath; Daniel V LaBarbera
Journal:  PLoS Negl Trop Dis       Date:  2017-08-09

4.  Telomerase immortalization of human corneal endothelial cells yields functional hexagonal monolayers.

Authors:  Thore Schmedt; Yuming Chen; Tracy T Nguyen; Shimin Li; Joseph A Bonanno; Ula V Jurkunas
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

5.  Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity.

Authors:  Kerrilyn Naidoo; Sibusiso T Malindisa; Tyrone C Otgaar; Martin Bernert; Bianca Da Costa Dias; Eloise Ferreira; Uwe Reusch; Stefan Knackmuss; Melvyn Little; Stefan F T Weiss; Boitelo T Letsolo
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.